FDA
-
-
-
-
-
-
-
SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution
-
-
-
-
-
-
-
Study finds proteomic risk scores for cardiovascular disease from SomaSignal® Cardio DM™ tests could support physicians in managing patient outcomes
-
-
-
-
-
-
-
SomaLogic to Announce First Quarter 2022 Financial Results
-
-
-
-
-
-
-
SomaLogic to Participate in the Cowen 42nd Annual Health Care Conference
-
-
-
-
-
-
-
Somalogic (SLGC) Reports Prelim FY21 Revenues of Over $79M
-
-
-
-
-
-
-
SomaLogic to Participate in the 40th Annual J.P. Morgan Healthcare Conference
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

